| 1 |
Sung H, Ferlay J, Siegel RL, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries[J]. CA Cancer J Clin, 2021, 71(3): 209-249.
|
| 2 |
陈旭，牛凯，孙建国. 放疗联合免疫治疗对驱动基因阴性NSCLC的困惑分析及应对策略[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(3): 341-348.
|
| 3 |
Zheng J, Jia L, Mori S, et al. Evaluation of metastatic niches in distant organs after surgical removal of tumor-bearing lymph nodes[J]. BMC cancer, 2018, 18(1): 608.
|
| 4 |
Erler JT, Bennewith KL, Cox TR, et al. Hypoxia-induced lysyl oxidase is a critical mediator of bone marrow cell recruitment to form the premetastatic niche[J]. Cancer cell, 2009, 15(1): 35-44.
|
| 5 |
Perryman L, Erler JT. Lysyl oxidase in cancer research[J]. Future Oncol, 2014, 10(9): 1709-1717.
|
| 6 |
Li YL, Hung WC. Reprogramming of sentinel lymph node microenvironment during tumor metastasis[J]. J Biomed Sci, 2022, 29(1): 84.
|
| 7 |
Domogalla MP, Rostan PV, Raker VK, et al. Tolerance through education: how tolerogenic dendritic cells shape immunity[J]. Front Immunol, 2017, 8: 1764.
|
| 8 |
Devito NC, Plebanek MP, Theivanthiran B, et al. Role of tumor-mediated dendritic cell tolerization in immune evasion [J]. Front Immunol, 2019, 10: 2876.
|
| 9 |
Van Pul KM, Vuylsteke R, Van De Ven R, et al. Selectively hampered activation of lymph node-resident dendritic cells precedes profound T cell suppression and metastatic spread in the breast cancer sentinel lymph node[J]. J Immunother Cancer, 2019, 7(1): 133.
|
| 10 |
Aspord C, Leccia M T, Charles J, et al. Plasmacytoid dendritic cells support melanoma progression by promoting Th2 and regulatory immunity through OX40L and ICOSL [J]. Cancer immunol Res, 2013, 1(6): 402-415.
|
| 11 |
Baban B, Chandler PR, Sharma MD, et al. IDO activates regulatory T cells and blocks their conversion into Th17-like T cells [J]. J Immunol, 2009, 183(4): 2475-2483.
|
| 12 |
Qian BZ, Pollard JW. Macrophage diversity enhances tumor progression and metastasis[J]. Cell, 2010, 141(1): 39-51.
|
| 13 |
Newman AM, Liu CL, Green MR, et al. Robust enumeration of cell subsets from tissue expression profiles[J]. Nat Methods, 2015, 12(5): 453-457.
|
| 14 |
Dong B, Wu C, Huang L, et al. Macrophage-related SPP1 as a potential biomarker for early lymph node metastasis in lung adenocarcinoma[J]. Front Cell Dev Biol, 2021, 9: 739358.
|
| 15 |
Wu K, Lin K, Li X, et al. Redefining tumor-associated macrophage subpopulations and functions in the tumor microenvironment[J]. Front Immunol, 2020, 11: 1731.
|
| 16 |
Wang Y, Wang J, Yang C, et al. A study of the correlation between M2 macrophages and lymph node metastasis of colorectal carcinoma[J]. World J Surg Oncol 2021, 19(1): 91.
|
| 17 |
Kong W, Wei M, Liu R, et al. Prognostic value of CD169-positive macrophages in various tumors: a meta-analysis[J]. Bioengineered, 2021, 12(1): 8505-8514.
|
| 18 |
Peng JM, Su YL. Lymph node metastasis and tumor-educated immune tolerance: Potential therapeutic targets against distant metastasis[J]. Biochem Pharmacol, 2023, 215: 115731.
|
| 19 |
Masucci MT, Minopoli M, Carriero MV. Tumor associated neutrophils. their role in tumorigenesis, metastasis, prognosis and therapy[J]. Front Oncol, 2019, 9: 1146.
|
| 20 |
Hiramatsu S, Tanaka H, Nishimura J, et al. Neutrophils in primary gastric tumors are correlated with neutrophil infiltration in tumor-draining lymph nodes and the systemic inflammatory response[J]. BMC Immunology, 2018, 19(1): 13.
|
| 21 |
Raniszewska A, Vroman H, Dumoulin D, et al. PD-L1(＋) lung cancer stem cells modify the metastatic lymph-node immunomicroenvironment in nsclc patients[J]. Cancer Immunology Immunotherapy, 2021, 70(2): 453-461.
|
| 22 |
Kwiecien I, Rutkowska E, Sokołowski R, et al. Effector memory T cells and CD45RO＋ regulatory T cells in metastatic vs. non-metastatic lymph nodes in lung cancer patients[J]. Front Immunol, 2022, 13: 864497.
|
| 23 |
Rahim MK, Okholm TLH, Jones KB, et al. Dynamic CD8(＋) T cell responses to cancer immunotherapy in human regional lymph nodes are disrupted in metastatic lymph nodes[J]. Cell, 2023, 186(6): 1127-1143.
|
| 24 |
Kotsakis A, Koinis F, Katsarou A, et al. Prognostic value of circulating regulatory T cell subsets in untreated non-small cell lung cancer patients[J]. Sci Rep, 2016, 6: 39247.
|
| 25 |
Reticker-Flynn NE, Zhang W, Belk JA, et al. Lymph node colonization induces tumor-immune tolerance to promote distant metastasis[J]. Cell, 2022, 185(11): 1924-42.e23.
|
| 26 |
Mickel RA, Kessler DJ, Taylor JM, et al. Natural killer cell cytotoxicity in the peripheral blood, cervical lymph nodes, and tumor of head and neck cancer patients[J]. Cancer Res, 1988, 48(17): 5017-5022.
|
| 27 |
Teramoto K, Igarashi T, Kataoka Y, et al. Clinical significance of PD-L1-positive cancer-associated fibroblasts in pN0M0 non-small cell lung cancer[J]. Lung Cancer, 2019, 137: 56-63.
|
| 28 |
Zhai WY, Zhao ZR, Chen S, et al. Response of primary tumor and lymph node in non-small cell lung cancer after neoadjuvant immunotherapy: a pooled analysis[J]. J Immunother Cancer, 2022, 10(9): e005160.
|
| 29 |
孟芸畅，许可，宋勇. 新辅助免疫治疗在可切除非小细胞肺癌中的研究进展[J/OL]. 中华肺部疾病杂志(电子版), 2023, 16(5): 734-738.
|
| 30 |
Yang G, Cai S, Hu M, et al. Functional status and spatial architecture of tumor-infiltrating CD8＋ T cells are associated with lymph node metastases in non-small cell lung cancer[J]. J Transl Med, 2023, 21(1): 320.
|
| 31 |
Du C, Chen Y, Zhou Y, et al. Neo-adjuvant chemotherapy plus immunotherapy in resectable N1/N2 NSCLC[J]. BMC cancer, 2023, 23(1): 1260.
|
| 32 |
Barua S, Fang P, Sharma A, et al. Spatial interaction of tumor cells and regulatory T cells correlates with survival in non-small cell lung cancer[J]. Lung Cancer, 2018, 117: 73-79.
|
| 33 |
邹琴，龙玲，叶容，等. PD-1抑制剂免疫治疗NSCLC所致反应性毛细血管增生症的研究进展[J/OL]. 中华肺部疾病杂志(电子版), 2023, 16(2): 278-280.
|
| 34 |
Ishiguro F, Matsuo K, Fukui T, et al. Effect of selective lymph node dissection based on patterns of lobe-specific lymph node metastases on patient outcome in patients with resectable non-small cell lung cancer: a large-scale retrospective cohort study applying a propensity score[J]. J Thorac Cardiovasc Surg, 2010, 139(4): 1001-1006.
|